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Abstract
The relationships between the levels of transcripts and the levels of the proteins they encode have not been examined
comprehensively in mammals, although previous work in plants and yeast suggest a surprisingly modest correlation. We
have examined this issue using a genetic approach in which natural variations were used to perturb both transcript levels
and protein levels among inbred strains of mice. We quantified over 5,000 peptides and over 22,000 transcripts in livers of
97 inbred and recombinant inbred strains and focused on the 7,185 most heritable transcripts and 486 most reliable
proteins. The transcript levels were quantified by microarray analysis in three replicates and the proteins were quantified by
Liquid Chromatography–Mass Spectrometry using O(18)-reference-based isotope labeling approach. We show that the
levels of transcripts and proteins correlate significantly for only about half of the genes tested, with an average correlation
of 0.27, and the correlations of transcripts and proteins varied depending on the cellular location and biological function of
the gene. We examined technical and biological factors that could contribute to the modest correlation. For example,
differential splicing clearly affects the analyses for certain genes; but, based on deep sequencing, this does not substantially
contribute to the overall estimate of the correlation. We also employed genome-wide association analyses to map loci
controlling both transcript and protein levels. Surprisingly, little overlap was observed between the protein- and transcript-
mapped loci. We have typed numerous clinically relevant traits among the strains, including adiposity, lipoprotein levels,
and tissue parameters. Using correlation analysis, we found that a low number of clinical trait relationships are preserved
between the protein and mRNA gene products and that the majority of such relationships are specific to either the protein
levels or transcript levels. Surprisingly, transcript levels were more strongly correlated with clinical traits than protein levels.
In light of the widespread use of high-throughput technologies in both clinical and basic research, the results presented
have practical as well as basic implications.
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Introduction
An underlying assumption in many biological studies is the
concordance of transcript and protein levels during the flow of
information from DNA to phenotype. Clearly, protein levels are
greatly influenced by post-translational processing and inherent
variations in stability but, in general, it is assumed that
perturbations of transcript levels are substantially correlated with
PLoS Genetics | www.plosgenetics.org 1 June 2011 | Volume 7 | Issue 6 | e1001393protein levels. The extent to which this occurs, however, remains
poorly understood and understanding the relationships across
scales, from DNA to phenotype, has both practical and basic
implications. For example, ‘‘genetical genomics’’ studies examine
transcript levels as a function of genetic variation and use this
information to construct models, such as interaction networks, to
explain complex phenotypes [1–8]. Systems based approaches, in
particular, have relied heavily on transcriptome data [9].
Concordance of protein and transcript levels has been studied in
yeast and plants. A recent comparative study in a yeast segregating
population showed that there is a significant but modest
correlation between transcript and protein levels [10]. Moreover,
this report also found that, in general, loci that influence protein
abundance are different from those affecting transcript abun-
dance. A similar comparative analysis of molecular phenotype
mapping in Arabidopsis [11] was reported subsequently. In this
report the authors investigated the commonality of hotspot loci
(defined as loci affecting a large number of traits within each
biological class) across various biological scales and observed a
general theme consistent with the phenotypic buffering of
perturbations affecting molecular phenotypes as one looks to
scales further away from the DNA variation (e.g. proteome vs
transcriptome). Both of these reports emphasize the value gained
from bringing together information from various biological scales,
as each dataset will add new information to the phenotypic effect
of DNA variation.
We now report global analysis of transcript-protein relationships
in mice using a genetic approach involving thousands of naturally
occurring perturbations. For this, we have utilized a recently
developed panel of permanent inbred strains of mice, termed the
Hybrid Mouse Diversity Panel (HMDP), that allows high
resolution mapping of complex traits [12]. We chose to examine
protein and transcript levels in liver given the importance of the
organ in metabolic traits relevant to disease.
Results
Study design
The experimental design of our study is depicted in Figure 1. To
study the relationship between transcript and protein levels
globally, we examined 97 inbred strains of mice of the HMDP
representing a wide range of genetic diversity, including
,11,000,000 single nucleotide polymorphisms as well as copy
number variations [13,14]. As we have shown previously, this
population includes thousands of expression quantitative trait loci
(eQTL) that can be mapped in the population using association
analysis with correction for population structure using a mixed
model algorithm [12]. The resolution achieved in this way is, on
average, one to two orders of magnitude narrower than that using
linkage analysis [12]. Livers from the 97 strains were quantitatively
analyzed for global transcript levels using the Affymetrix HT-MG-
430A platform and for protein levels using LC-MS employing
AMT tag approach for identification and
16O/
18O labeling for
quantification [12,15]. In the latter, each individually processed
and unlabeled sample is spiked with the
18O labeled ‘‘universal’’
reference pool (i.e. the pool made from mixing together the same
amount of isolated proteins from all samples) providing an internal
standard for accurate measurement of protein abundance across
biological samples. This dual-quantification, which combines the
label-free and isotope labeling techniques, has been shown to be
significantly superior over label-free methods in terms of
quantification precision [15] and offers a simple, robust, and a
more precise alternative to other proteomic techniques for
studying variations in protein levels across large biological samples.
In the LC-MS dataset, we also included 10 technical replicates
from the C57BL/6J strain to measure the reproducibility of the
sample preparation and technology which we describe in detail
below.
Peptide and microarray data quantification and quality
One technical issue for proteomic analysis relates to how
peptides with non-synonymous coding SNPs would present
themselves in the correlation and association analyses. In order
to annotate peptides detected by the tandem LC- MS/MS
fragmentation patterns, the mass spectra are matched against a
pre-established known reference database. In our case this
database, which was built from the pool of all the inbred strains
in the HMDP panel, was created by annotating the peptides
against the reference sequence (C57BL/6J strain) followed by
filtering out those peptides which have non-synonymous coding
SNPs documented in public database for any of the HMDP
strains. As a result of this preprocessing step, the peptides identified
by LC-MS were limited to those that did not contain known non-
synonymous SNPs in their amino acid sequences.
From the original 5363 peptides measured, we selected peptides
that a) had less than 50% missing measurements in the whole
population, b) had no internal lysine or arginine, and c) aligned
uniquely to one Ensembl gene. Fifty four percent of peptides (2893
peptides) passed these initial selection criteria. To assess the quality
of the measurements, we investigated the amount of technical
noise in the peptides selected. Having the control technical
replicates allowed us to measure the reproducibility of the LC-MS
measurement and assess whether the variation in the levels of the
selected peptides in the HMDP population was due to technical or
genetic variation. The distribution of the variance in the control
mice and in the HMDP panel are shown in Figure 2A (the blue
histogram). The mean and median across the ten replicates were
0.19 and 0.08 (the grey histogram), respectively, suggesting that,
for most peptides, the measurements were robust. In contrast, the
distribution of the variance was much broader in the genetic
population where the mean and median of variances across all the
peptides were 0.2 and 0.3 respectively (Figure 2A, the blue
histogram).
The relationship between RNA levels and peptide levels across
the HMDP genetic perturbations would be a function of the
Author Summary
An old dogma in biology states that, in every cell, the flow
of biological information is from DNA to RNA to proteins
and that the latter act as a working force to determine the
organism’s phenotype. This model predicts that changes in
DNA that affect the clinical phenotype should also similarly
change the cellular levels of RNA and protein levels. In this
report, we test this prediction by looking at the
concordance between DNA variation in population of
mouse inbred strains, the RNA and protein variation in the
liver tissue of these mice, and variation in metabolic
phenotypes. We show that the relationship between
various biological traits is not simple and that there is
relatively little concordance of RNA levels and the
corresponding protein levels in response to DNA pertur-
bations. In addition, we also find that, surprisingly,
metabolic traits correlate better to RNA levels than to
protein levels. In light of current efforts in searching for the
molecular bases of disease susceptibility in humans, our
findings highlight the complexity of information flow that
underlies clinical outcomes.
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nongenetic/technical variations in peptide quantification. Thus,
we defined a ‘‘signal to noise’’ measure for each peptide as the
ratio of the total variance in the HMDP over the variance in the
ten replicates. The variance in the ten replicates would be due to
nongenetic biologic variance as well as technical variance (herein
termed ‘‘noise’’) while the total HMDP variance would include
genetic variance, nongenetic biologic variance, and technical
variance. Accordingly, a large value of signal to noise could either
mean large genetic variation, small nongenetic variation, or both.
Conversely, a smaller value for signal to noise would either mean
small genetic variation, large nongenetic variation, or both. As can
be seen in Figure 2B, signal to noise ratios varied significantly
across different peptides.
We complemented the LC/MS studies for a small set of
proteins (11) by performing immunoblot quantitation in 9 of the
HMDP strains. Over half of the peptides exhibited significant
discrepancies in relative levels using the two methods and those
with small ‘‘signal to noise’’ ratios (small genetic variation and/or
large noise component) exhibited reduced correlations with the
immunoblotting results (p-value=3.3610
25). Although immuno-
blotting is semi-quantitative, these results suggest that peptides
with a large signal to noise ratio will provide the best estimates of
the true relationship between RNA levels and protein levels.
(Immunoblot results are presented in Table S1, Table S2, and
Figure S1).
Transcript levels in inbred stains were measured by profiling
three mice for each strain, using Affymetrix MOE430A platform,
and taking the average of expression over the three biological
replicates. This design provided us with an opportunity to a) better
estimate the ‘‘true’’ values for the mRNA levels in each strain and
b) estimate the heritability of each probeset across the HMDP
population. The distribution of heritability estimates is shown in
Figure 2C. Consistent with previous reports [16], we detected a
broad spectrum of heritability estimates for the transcript levels
ranging from 0.07 to 0.95. Using ANOVA, we assigned
significance to the heritability values obtained for each probeset
and found that for as many as 50% of the probesets (11248
probesets), there was a significant (p-value,0.05 for strain term)
genetic component affecting the transcript levels.
Previous reports have documented conflicting results about the
reproducibility measurements generated by microarray platforms
[17–21]. To investigate this in our dataset, we compared the
expression levels measured by the Affymetrix microarray to the
expression levels measured by next generation sequencing (NGS)
in small subset of inbred strains. Using Illumina’s Genome
Analyzer we profiled the liver transcriptome of one C57BL/6J and
one DBA/2J mouse and generated ,17,000,000 sequences for the
fragmented mRNAs for each strain. Using Tophat [22] and
Cufflink [23] algorithms, we were able to uniquely align and count
4,800,000 and 7,000,000 sequences for C57BL/6J and DBA/2J
respectively (See Materials and Methods). After sequence align-
ment and quantification of the read counts, we compared the
transcriptome of the each strain against the microarray data
generated by the Affymetrix MOE430a platform (Figure 2D). This
comparison revealed a high concordance between the data
obtained from two technologies (Spearman correlation coefficient
of 0.69 for both C57BL/6J and DBA/2 samples). These results
were similar to a previous cross-platform comparative study [24]
and indicated that, for most transcripts, microarray data produce a
highly reliable estimate of transcript levels.
Based on the results reported above, in order to enrich for high
quality data and provide a better estimate of true relationships
between transcript and protein data, we focused on transcript and
peptide data with significant genetic and biological variation. For
peptide data, we used the signal to noise ratio parameter to further
filter the noisy peptides from our dataset. The cutoff we chose for
filtering peptides was a signal to noise ratio of 2. After removing
Figure 1. A schematic representation of the experimental design. 97 inbred and recombinant inbred strains in the HMDP panel were utilized
to study the relationships between transcripts, proteins, and clinical traits. The relationships between proteins and transcripts were assessed at the
biological level by the overall correlation across datasets, and at the genetic level by comparing the genome-wide association profiles of the two
datasets. The biological relationship between the transcripts and proteins was also assessed in the context of the physiological phenotypes by
relating these two datasets to the 42 clinical traits measured in the HMDP panel.
doi:10.1371/journal.pgen.1001393.g001
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Dataset S1 for the expression and Dataset S2 for the annotation of
the peptides). These 1543 peptides represented 486 Ensembl
Genes from which 39% were represented by only one peptide and
the remaining 60% were represented by two or more peptides
(Figure 2E). The most abundant number of peptides (.20 peptides
per gene) was found for 2 genes, aldehyde dehydrogenase 1 family,
member L1 (Aldh1l1), and carbamoyl-phosphate synthetase 1 (Cps1). For
the transcript data, we focused only on those transcripts that had a)
a significant genetic component underlying their variation
(heritability p-value,0.05), and b) unambiguous annotation in
the Ensembl database. To comprehensively compare the tran-
scripts and peptides, we also included those probesets that were
annotated as the same Ensembl gene/transcript as one of the
peptides in the protein data. This resulted in the total of 9896
probesets (representing 7185 Ensembl genes) from the initial
22670 probesets.
Proteome and transcriptome representation
To investigate the range of gene products present in the filtered
datasets, we generated a separate list of ‘‘GO Slim’’ terms for each
of the three major GO categories (Cellular Compartment or
‘‘CC’’, Molecular Function or ‘‘MF’’, and Biological Process or
‘‘BP’’) and used the ‘‘GO Term Mapper’’ website (http://go.
princeton.edu/cgi-bin/GOTermMapper) to classify and count the
number of proteins and transcripts in each of the 3 major GO
categories (Table S3). We also compared our results to the
background set (all genes annotated by Mouse Genome Infor-
matics) and using Fisher’s Exact test calculated the degree of
enrichment or underrepresentation for each GO class. Figure S2
depicts the results of this analysis for the Cellular Compartment
GO terms. While the proteome and transcriptome datasets
represent a wide range of gene products present in various cellular
compartments, the compartments are not equally represented. In
the protein data, mitochondrial genes were overwhelmingly the
largest set and in the transcript data the nuclear compartment was
at the top of the list for enriched CC GO terms. The enrichment
analysis showed that for both protein and transcript datasets the
majority of the GO terms tested were significantly over and under-
represented and these differences were more pronounced for the
protein data (Table S3). A likely explanation for this observation is
that the LC-MS analysis of the liver provides a biased sampling of
the proteome data (due to the abundance and/or cellular location
of the protein). The significant differences between the transcript
data and the background set may be partially explained by the bias
introduced in the design of the Affymetrix microarray. Alterna-
tively, since the transcript data by the virtue of filtering represent
the significantly heritable subset of all transcripts present on the
Affymetrix chip, one could postulate that in some cellular
compartments or cellular processes transcripts are more or less
likely to exhibit common genetic variation.
Modest concordance between transcript and protein
levels
We next examined the degree of concordance between the
transcript and protein levels. For this, we compared the transcript
and peptide measurements for every peptide-probeset pair that
mapped to the same Ensembl gene. This ‘‘gene-level’’ analysis
included 2010 peptide-probeset pairs (1342 peptides and 607
probesets) representing 396 Ensembl genes. Figure 3A shows the
correlation coefficient distribution for these 2010 peptide-probeset
pairs. Highly significant positive correlation (p-value,1e-06,
r.0.46) between RNA and protein was found for 21% of the
genes (85 out of 396) and ,15% of the peptide-probeset pairs (291
out of 2010). The most significant correlation (r=0.87) was found
for the glyoxalase 1 gene (Glo1) where the peptide and transcript of
this gene correlated (Figure S3). Overall, we found that the
relationship between mRNA and protein levels was modest (mean
r=0.27) and for 39% of the pairs (761 of 2010) the mRNA and
protein levels did not correlate significantly at the nominal 0.05 p-
value threshold. Our estimate of average correlation between
mRNA and protein was slightly higher than those reported in
other organisms, perhaps due to recent improvements in the LC-
MS technology and/or statistical power.
Next, we examined if the amount of technical noise and/or lack
of genetic variation could explain the modest correlation between
mRNA and peptide data. For this we classified each peptide based
on the signal to noise ratio (defined earlier) and looked at the
median correlation between mRNA and peptides within each
group. As shown in Figure 3B, we found that as the ratio of signal
to noise increases so does the correlation between the mRNA and
peptide levels of the gene. In fact the median correlation for the
least noisy group, comprising peptides with signal to noise ratio
.90%, was twice as large as the noisiest group of peptides
(peptides with signal to noise ratio ,60%). These results suggests
that the modest correlation between peptides and mRNA observed
in our study is partially due to either the presence of significant
nongenetic variation or small genetic variation in some proteins.
Alternative splicing is not a significant contributing factor
to the overall modest correlation of transcript and
protein levels
Aside from lack of genetic variation in peptides, another
plausible explanation for the lack of high correlation between
peptides and probesets could be the analytic approach chosen to
calculate correlations. In our study, we estimated the relationship
between mRNA and proteins by examining the correlations
between pairs of peptides and probesets that were annotated to the
same gene without considering the isoform information for that
gene. The choice of analytic approach presented here was mainly
due to the limitation of the technology we used to measure the
transcript levels. The probesets on the Affymetrix microarrays are
designed to hybridize mainly to the transcripts 39 end. Such design
will fail to accurately measure the levels of isoforms which are
identical at the 39 end but are differentially regulated at the
transcript level. The inability to measure isoform specific
expression can clearly impact the mRNA-protein correlation
results for certain peptides which represent specific isoforms as
LC-MS data may include peptides unique to a gene’s isoform.
Figure 4A and 4B illustrate an example of differential isoform
regulation identified in the LC-MS data. Acox1 (acyl-Coenzyme A
oxidase 1, palmitoyl) is a peroxisomal gene involved in fatty acid beta-
Figure 2. Proteome and transcriptome data quality. A) Reliability of peptide measurement in LC-MS. The distribution of variance among the
technical replicates in the LC-MS data (grey plot) and in the HMDP population (blue plot). B) The frequency of peptides with varying amount as
defined by the ‘‘signal to noise’’ ratio. C) Distribution of heritability (fraction of total variance attributed to genetics) in the transcript dataset. The
dashed line depicts the significant heritability estimates (p-value,0.05) D) Comparison of Affymetrix data with the Next Generation Sequencing data.
E) Number of peptides per gene in the filtered peptide dataset.
doi:10.1371/journal.pgen.1001393.g002
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and its deficiency causes pseudoneonatal adrenoleukodystrophy
[25] in humans. This gene produces four protein-coding products
(Acox1-001, Acox1-002, Acox1-003, and Acox1-201 as denoted in
Ensembl genome browser) shown in Figure 4A (bottom panel). All
isoforms except for ‘‘Acox1-002’’ include exon 4 of this gene. In
LC-MS data, 20 peptides were measured for this protein. One of
these 20 peptides (‘‘GHPEPLDLHLGMFLPTLLHQATEEQ-
QER’’) maps to the exon 4 sequence of this gene, thus, does not
represent the ‘‘Acox1-002’’ isoform which skips this exon.
Examining the expression profile and correlation of these 20
peptides revealed that all peptides representing ‘‘Acox1-002’’
isoform are highly intercorrelated (mean r=0.86, Figure 4B) and
exhibit a similar expression profile (Figure 4A, top panel), but none
have either similarity in expression profile or significant correlation
with the peptide mapping to the exon 4 which is skipped in Acox1-
002 isoform (mean r=0.23, Figure 4A top panel, and 4B). This
suggests that Acox1-002 isoform (with the skipped exon 4) is the
main isoform underlying the significant correlation among 19 of
the 20 peptides identified by LC-MS in our genetic population.
This example illustrates that the LC-MS data contain information
on differential regulation of isoforms, in contrast to the microarray
data.
To investigate if our inability to measure isoform specific
expression by microarrays could explain the lack of concordance
between mRNA and peptides, we utilized the next generation
sequencing data generated for the two inbred strains described
earlier. This dataset provided us with an opportunity to examine
the transcript level expression of the exons measured by NGS
with the protein level expression of exons measured by the LC-
MS. To investigate this, for each peptide we calculated the count
of exons in RNA-Seq data for two strains. We then compared the
DBA to B6 ratio of each exon in the peptide data to the DBA to
B6 ratio of normalized sequence counts (reported in FPKM units)
in the RNA-Seq data. The results of these comparisons are shown
in Figure 4C. Similar to the gene-level analysis, the exon level
analysis of all the filtered data also suggested a modest
relationship between the exon counts in the mRNA data vs exon
levels in the LC-MS data (r
2=0.02). This global analysis
provided no support for the presence of differential splicing/
isoform regulation as being a significant factor in the mRNA and
protein overall relationships observed between LC-MS and
microarray data. The relationship between RNA-Seq data and
LC-MS peptide data is particularly strong (r=0.42) for those
peptides exhibiting a strong correlation (r.0.5) with microarray
data (Figure 4C).
In an alternate approach to study the effect of differential
splicing on the correlation pattern, we examined our LC-MS data
at the isoform level and compared the results to the gene level
analysis. For this, we grouped various peptides of each protein into
unique and mutually exclusive clusters of known isoforms as
defined by the Ensembl database. In this classification we allowed
peptides to only represent one Ensembl protein ID and excluded
any peptide which matched with two or more Ensembl proteins.
Focusing on clusters with at least two peptides assigned to a cluster,
we calculated the within cluster correlation of of peptides and
compared the average within-cluster correlation to the average
correlation of peptides at the gene level analysis. The average
correlation of peptides at the gene level analysis was estimated at
0.47. In comparison, the average within cluster correlation of
peptides representing the same isoforms was estimated to be 0.52.
Combined with the NGS analysis described earlier, the small and
nonsignificant increase in the peptide concordance after taking
into account the isoform membership provides little support for
differential regulation of splicing/isoform expression as a signifi-
cant factor underlying the observed modest correlation between
transcripts and proteins.
Differential relationships of proteins and transcripts to
clinical traits
In light of the modest correlation observed between the
transcript and protein pairs, we examined the relationship of each
of these two datasets with clinical traits. In our HMDP panel, we
have previously measured a set of 42, some interrelated, metabolic
traits (see Materials and Methods). In this analysis, in order to
make a direct comparison across the two datasets, we once again
focused on the 396 genes for which we had at least one peptide
and one transcript measurement. At the 5% false discovery rate,
we observed that three quarters of probesets (457 from the total
607) significantly correlated with at least one of the clinical traits.
In contrast, at the same false discovery rate, only 28% of the total
Figure 3. Relationships between protein levels and transcript
levels. A) Histogram of correlation coefficients computed peptides and
probesets representing the same gene. The median correlation
coefficient is 0.27. B) Classification of correlations between probeset-
peptides based on signal to noise ratio in the peptide data (larger signal
to noise depicts less technical variation in the peptide measurement).
doi:10.1371/journal.pgen.1001393.g003
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PLoS Genetics | www.plosgenetics.org 6 June 2011 | Volume 7 | Issue 6 | e1001393Figure 4. Isoform-specific analysis of peptide data. A) An example of differential regulation of isoforms detected in the LC-MS data. Top panel,
comparison of similarity in expression variation of 20 peptides measured for Acox1. Grey plots illustrate the expression variation among inbred mice
for 19 peptides which represent all four Acox1 isoforms. Red plot illustrated the expression profile of the peptide representing the isoforms skipping
Global Mouse mRNA and Protein Levels Comparison
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least one of the 42 phenotypes. Despite the fact that the starting
number of peptides was twice the number of probesets (1342 and
607), the total number of significant correlations for the peptides
was only about half the number found for the probesets (2206 vs
1107). The same biased pattern was also observed at other
statistical thresholds as shown in Table 1. In addition to probeset-
pair analysis, we also carried a similar analysis at the gene level to
estimate what fraction of starting genes (396 total genes) a) exhibit
consistent relationship with clinical traits both at the transcript
level and the protein level b) exhibit trait relationships unique to
either of the two molecular phenotypes. From the 396 genes, 325
genes had at least one significant correlation at the 5%FDR with
clinical phenotypes and 162 had at least one significant correlation
with phenotypes at the protein level (Table 1). At the transcript
level, the total number of significant correlations amounted to
1781 vs 556 found at the protein level. From these, 234 relations
were found to be common for transcript and protein of the same
genes and 1547 were unique to transcripts only (Figure 5A).
Despite this overwhelming bias toward better correlation of
transcripts, we also found 322 unique relations at the protein level
(Table 1 and Figure 5A). Altogether, about half the significant
protein-trait correlations also exhibited transcript-trait correla-
tions, but only 15% of the significant transcript-trait correlations
exhibited corresponding protein-trait correlations.
Relationships as a function of Gene Ontology categories
and KEGG pathways
We sought to examine whether the concordance between
protein and transcript data was dependent on the biological
function and/or cellular location of the gene product. For this we
restricted the list of genes within each of the 3 major GO_slim
terms described earlier to the 396 genes for which we had at least
one probeset and one peptide measured. We then defined the
average relationship between protein and transcript products of
the genes within each GO category by computing the correlation
between the gene products and taking the average of these
correlations. The three panels in Figure S4 show the average
correlations of the transcript and protein product of the genes
grouped by their assigned GO categories. Striking differences in
the concordance between proteins and transcripts across some of
the GO categories were observed. For example, for Cellular
Compartment GO terms (CC), we found that peroxisomal and ER
genes have on average a better correlation between protein and
transcript products than other cellular compartments. We also
found that for some of the GO categories the similarity between
protein and transcript levels was almost non-existent (for example
in BP the ‘‘cell growth’’ class, Figure S4C). To assess the
significance of these observations, for each GO class we created
100,000 bootstrap datasets (each the size of the number of genes
assigned to the respective GO category) containing correlation
coefficient p-values randomly selected from the pool of peptide-
probeset correlation p-values. We then assessed the significance of
observed averaged correlation p-value for each class by comparing
it to the distribution of the averaged p-values in the bootstrapped
dataset (Table S4). In some GO groups, we found a class of genes
for which the relationship between the transcript level and protein
level is significantly better than for other GO groups. We also
found GO classes in which the transcript levels and protein levels
of the genes were significantly discordant (i.e. the relationship
between protein and transcript was significantly less than what
would be expected by chance). For example, in MF we found that
genes classified as having a role in ‘‘electron carrier activity’’ had a
strong relationship among the protein and transcript levels (p-
value=8.9e-03) and this relationship is significantly compromised
for genes with ‘‘transporter activity’’ (p-value=4e-05). Another
example of discordant group was genes involved in the translation
process (p-value,1e-05). Interestingly, the ‘‘translation’’ category
has been proposed recently to be involved in phenotypic buffering
in a yeast genetic interaction network. Overall, these results
indicate that cellular compartments and biological processes vary
in the degree to which the linear relationships between transcript
levels and their protein products are conserved.
We also examined the level of concordance among transcripts
and proteins of genes that are members of the same biological
pathway. For this, we focused on 212 biological pathways on the
KEGG website (http://www.genome.jp/kegg/). We annotated
the peptides and probesets according to their pathway member-
ship as determined by their Ensembl gene IDs. Ninety nine out of
212 pathways contained genes for which we had both more than
one transcript and more than one protein measured. Focusing on
these 99 pathways, we then performed the following three
correlation analyses: 1) correlation between peptides belonging
exon 4. Bottom panel, Ensembl genome browser’s schematic representation of four Acox1 isoforms. Arrow points to Acox1-002 isoform which skips
exon 4. B) Concordance between Acox1 peptides. The left boxplot depicts correlations among peptides that include Acox1-002 isoform. The right
boxplot depicts correlations between the peptide mapping to exon 4 and all other peptides. The scatter points overlaid on each boxplot represent
the pair-wise correlation values. C) Exon level analysis of peptide measurements by LC-MS and transcript measurements as measured by NGS in the
livers of the B6 and DBA inbred strains. The black dots depict the relationships examined by comparing peptide data to microarray data and the red
dots represent the highly significant relations found by peptide comparison with the microarray data. The lines depict the best fit as predicted by
linear regression (black line=regression of all peptides, red line=regression of highly significant peptides).
doi:10.1371/journal.pgen.1001393.g004
Table 1. Relationship of PT-pairs with clinical traits.
# Trait Correlations
Unique to Proteins
# Trait Correlations
Unique to Transcripts
# Trait Correlations Shared
Between Transcripts and
Proteins
# Proteins with
Significant
Correlation (%)
# Transcripts with
Significant Correlation
(%)
0.1% FDR 35 272 17 24 (6) 122 (31)
1% FDR 93 704 71 64 (16) 217 (55)
5% FDR 322 1547 234 162 (41) 325 (82)
doi:10.1371/journal.pgen.1001393.t001
Global Mouse mRNA and Protein Levels Comparison
PLoS Genetics | www.plosgenetics.org 8 June 2011 | Volume 7 | Issue 6 | e1001393to the same pathway, 2) correlation between probesets belonging
to the same pathway, 3) correlation between probesets and
peptides belonging to the same pathway. Comparing the results of
these three analyses suggests that overall within-transcript
correlation of biological pathway genes is higher than within-
protein correlations (0.20 vs 0.14 mean Spearman correlation
coefficients) (Figure 5B), and transcript-protein correlations are the
weakest of all (mean Spearman correlation coefficient of 0.11).
From the 99 pathways, 79 pathways had better between-transcript
correlations than between-protein correlations and 20 had better
between-protein correlations. We also observed that for most
pathways when there was good concordance between the
transcripts there was also good concordance between the peptides
of that pathway (r=0.39, Figure 5B).
Modest concordance of genetic loci controlling transcript
and protein levels
Next, we examined the genetic loci regulating protein and
transcript levels. It is known that the presence of SNP within probe
sequence can affect hybridization of the mRNA [26], leading to
both type-I and type-II errors in the genomewide association
analysis. In our Affymetrix dataset, as expected, we also observed a
significant effect of SNPs on genomewide association results for
fraction of the probes, as judged by comparing the significance
level for local eQTLs between probesets before and after masking
of probes containing publicly available SNPs (see Text S1 and
Table S5 for details, and Dataset S3 for the list of probes which
were masked from each probeset due to the presence of SNP). To
minimize this technical artifact, we removed all the SNP-
containing probes from their corresponding probeset before
normalization of the data and eliminated all the probesets which
contained 8 or more probes with SNPs (,300 probesets fell in this
category). Therefore, all the data reported below were generated
from masked probesets.
We performed genomewide association on both transcriptome
and proteome datasets using 95,854 SNPs with minor allele
frequencies greater than 10% obtained from the Broad Institute
(http://www.broadinstitute.org/mouse/hapmap) and Wellcome
Trust Center (WTCHG) (see Materials and Methods for details).
To account for the population structure and genetic relatedness
among strains in the genome-wide association mapping, we
utilized the Efficient Mixed Modeling Algorithm (EMMA) [27].
Furthermore, haplotype analysis of the inbred strains has shown
the presence of over 60,000 haplotype blocks of varying size
throughout the genome of inbred strains [28]. Since the presence
of these blocks could be a source for overestimation of extent of
genetic regulation and false positive associations, for each
transcript and protein we removed significant associations due to
high linkage disequilibrium (defined as R-squared of 0.5 or larger
between genotypes). Since the transcript and protein data have
different variance properties, which may subsequently affect our
statistical power to detect associations in the two different datasets,
we avoided the use of the same statistical cutoff for each dataset.
Instead, in order to achieve a comparable genome-wide cutoff
across the two datasets, we made use of false discovery rate and
compared the two association results by restricting the genome-
wide mapping results of each dataset to a list of associations with a
similar false discovery rates. The results are summarized in Table 2
and the eQTL profile for the combined set is depicted in
Figure 6A. At the 5% genome-wide FDR cutoff (p-value,1.7e-05)
we identified 14463 associations for the transcript data (referred to
as ‘‘eQTL’’ for expression QTL). At this cutoff stringency, 63% of
the transcripts (6299 out of 9896) mapped to at least one locus and
roughly one third of the transcripts (3651 out of 9896) mapped to
two or more loci (Table 2). In contrast, at the same 5% FDR (p-
value,9.6e-06), we only found 1368 significant associations for the
proteins (referred to as ‘‘pQTL’’ for protein QTL). The fraction of
total proteins with significant association was 672 genes (43%)
Figure 5. Relationships between the peptide data and transcript data with clinical traits and biological pathways. A) Correlations of
transcriptome and proteome with clinical traits. A scatter plot of correlation coefficients between 607 probesets and 1343 peptides with 42 clinical
traits (peptide-trait correlations are plotted on the x-axis and probeset-trait correlations are plotted on the y-axis). Red points are those correlations
which were significant for transcripts only, green points are those correlations which were significant for protein data only and black points are those
which were not significant in either of the two datasets. B) Concordance of transcripts and proteins in 115 KEGG biological pathways.
doi:10.1371/journal.pgen.1001393.g005
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general, the mapping data for molecular phenotypes can be
subdivided into ‘‘local eQTLs/pQTLs’’ to highlight the presence
of genetic variation near/within the gene controlling the transcript
or protein levels and ‘‘distant eQTLs/pQTLs’’ to discover trans-
acting gene-locus interactions at the genetic level [29]. An
empirical calculation of haplotype blocks in the HMDP panel
(based on continuous stretch of SNPs with the R-squared value
above 0.5) showed an average size of 0.73 Mb and a range from
less than a kb to 11 Mb (median=0.25 Mb). Given this fine
mosaic structure in the HMDP genotypes, we defined a local
eQTL/pQTL as an eQTL/pQTL with the peak SNP located in
the 4 Mb window flanking 2 MB on either side of the transcription
start site and transcription termination site of the gene. Based on
this, from the total of 14463 significant associations in the
transcript data, 2066 were local and 12397 were distant eQTLs. In
the protein data the numbers of local and distant eQTLs were 144
and 1224, respectively. The proportion of variance explained by
the peak SNP in local pQTLs was 44%, local eQTL was 42%,
distant pQTL was 27%, and distant eQTL was 23%. The
difference in proportion of variance explained between the distant
pQTLs and distant eQTLs was highly significant (Student t-test p-
value,1e-16), however, a similar comparison showed no signif-
icant difference between the mean effect sizes of local pQTL and
local eQTLs (Figure S5). For each dataset, the proportion of
variance explained by the local SNPs was significantly larger, as
expected, as compared to the distant SNPs.
Absence of hotspot loci regulating numerous transcripts/
proteins
A previous study in plants found that a small number of loci
regulated the levels of many proteins [11]. Accordingly, we
examined our data for the existence of similar ‘‘hotspots’’. In the
transcript data, we found that the 14463 eQTLs mapped to 9108
distinct peak SNPs. Over 85% of these SNPs (8034 out of 9108)
were associated with either one or two transcripts and only a small
fraction (334 SNPs) were associated with five or more transcripts.
In the protein data, 1368 significant pQTLs mapped to 1088
Figure 6. Global analyses of proteome and transcriptome genetic regulation. A) Global eQTL profile for the 14463 eQTLs and 1368 pQTLs
superimposed on each other. In this plot, larger dots represent protein association and smaller dots represent transcript association. The diagonal line
with strong association depicts the local eQTLs and pQTLs and each off-diagonal dot depicts the location of distant eQTLs and pQTLs. B) eQTL
landscape for protein and transcript data. For each dataset, the genome was divided into 2 Mb bins and the number of eQTLs (grey) and pQTLs (red)
were counted separately in each bin as the windows were slid every 50 kb. The frequency of eQTLs and pQTLs in each window are plotted as the
fraction of total significant associations (14463 for transcripts and 1368 for proteins).
doi:10.1371/journal.pgen.1001393.g006
Table 2. Genome-wide association profiles for the proteome and the transcriptome data.
Global Analysis
Number of Probesets/
Peptides
Total Number
of Significant
Associations
Number of Probesets/
Peptides With at least
One Significant
Association (% Total
Phenotypes)
Number of Probesets/
Peptides with Local
Associations (% Total
Phenotypes)
Number of
Distant
Associations
Number of Probesets/
Peptides With More
Than One Significant
Association (% Total
Phenotypes)
Transcriptome 9896 14463 6299 (63%) 2066 (21%) 12397 3651 (37%)
Proteome 1543 1368 672 (43%) 144 (9%) 1224 339 (21%)
Transcript-
Protein Pairs
Number of Genes
(Number of Probesets/
Peptides)
Total Number of
Significant
Associations
Number of Genes
With at least One
Significant
Association (% Total
Genes)
Number of Genes
with Local
Associations (% of
Total Genes)
Number of
Distant
Associations
Number of Genes With
More Than One
Significant Association
(% Total Phenotypes)
Transcriptome 396 (607) 878 297 (75%) 79 (20%) 799 205 (51%)
Proteome 396 (1343) 920 242 (61%) 46 (9%) 874 171 (43%)
doi:10.1371/journal.pgen.1001393.t002
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associated with a single protein, 100 were associated with 2
proteins, and 14 SNPs were associated with 5 or more proteins.
From the 1368 peak markers associated with protein levels 438
(32%) were also a peak SNP for one or more transcripts. To
investigate if the distinct peak SNPs found in the transcript and
protein data map near each other, we divided the genome into
2 Mb bins and using a 50 kb sliding window counted the number
of associations in each bin. In the transcript data, the median
eQTL number/window was 8 and the highest number of
associations was found for bins on Chr 4 (from 98.7 Mb to
100.8 Mb) with 71 eQTLs, Chr 5 (from 80 Mb to 83.1 Mb, from
112.4 Mb to 114.4 Mb) with 79 and 75 eQTLs in each
respectively, Chr 7 (from 143.2 Mb to 146.2 Mb) with 78 eQTLs,
Chr 8 (from 93.0 Mb to 95.1 Mb) with 71 eQTLs, Chr 17 (from
43.8 Mb to 46.4 Mb) with 80 eQTLs, and Chr 18 (from 55.0 Mb
to 57.5 Mb) with 76 eQTLs. In the protein data, however, most
associations were randomly distributed except for a clustering of
associations on Chr 3 (from 36.5 Mb to 38.6 Mb) with 20 pQTLs
and Chr 11 (from 94.3 Mb to 96.7 Mb, and from 114.1 Mb to
118.1 Mb) with 19 and 21 pQTLs respectively (Figure 6B). These
results contrast to the previously published reports where hotspots
containing hundreds or thousands of eQTLs were observed
[30,31]. This could be partially explained by both our ability to
map molecular phenotypes with higher precision in the HMDP
panel and the relatively stringent genome-wide threshold chosen to
carry out the analysis. The eQTL hotspots on Chr 4 (from
98.7 Mb to 100.8 Mb) resides 6 Mb proximal and the Chr 5
hotspot (from 80 Mb to 83.1 Mb) resides 25 Mb distal to the Chr
5 hotspot reported recently in mouse-hamster radiation hybrid cell
line [32]. Despite the relative close distance in mapping, however,
we did not find a significant overlap between the genes mapping to
these two loci in the two studies.
Genetic regulation of transcript and protein levels
The global look at the eQTL profiles of the transcriptome and
proteome described above suggested that transcripts are more
extensively regulated at the genetic level than proteins. However,
since the transcriptome data is more comprehensive than the
protein data, the differences observed between two datasets might
be due to sampling bias. In order provide a measure of similarity
for genetic regulation of proteins and transcripts we restricted the
data to the set of 396 genes for which we had both protein and
transcript measurements available. As mentioned earlier, in this
restricted dataset the 396 genes are represented by twice as many
peptides as probesets (1343 peptides and 607 probesets). Similar to
the genome-wide global analysis, we avoided the use of single
statistical cutoff to compare association results across the transcript
and peptide datasets, as each dataset has its own variance
properties. Instead, we compiled separate lists of significant
associations for each dataset using the same FDR cutoff. Since
the FDR threshold is driven by the distribution of p-values in each
dataset, this allowed us to compare the two lists directly without
setting a single statistical cutoff for both datasets. Limiting the
mapping data to those associations that met the 5%FDR cutoff in
each dataset (p-value,1.7e-05 for transcripts and p-value,9.6e-
06 for proteins) we found that despite mapping twice as many
peptides as probesets the number of significant associations were
roughly equal (939 and 1083 significant associations for probesets
and peptides, respectively). This suggests that transcripts are twice
as likely to be genetically regulated as are peptides. Next, we
performed a gene level analysis where we assigned the associations
obtained in each data set to their respective genes and for each
gene investigated the degree of similarity in genetic regulation
across the protein and transcript dataset. As summarized in
Table 2 and consistent with the probeset/peptide analysis
described earlier, we found that the number of genes under
genetic regulation, as judged by fraction of total genes with at least
one significant genome-wide association, favors the transcript
dataset. Overall, from the initial 396 genes, 75% (297/396) of the
genes with transcript products had at least one significant result vs
61% (242/396) of the genes in the LC-MS dataset. The number of
genes with multiple eQTL and pQTL was 205 and 171,
respectively. We also looked at the comparison across datasets
after classifying the mapping results into local and distant eQTL
and pQTL. For distant associations, 281 genes mapped to 799
distinct loci in the transcript dataset and 236 genes mapped to 874
unique genomic locations in protein dataset. Overlapping the
association results from the two datasets for distant eQTL/
pQTLs, we found that only 25 loci overlap with each other. From
these 25 loci, 7 loci had the same peak SNP between the pQTL
and the eQTL and in the remaining 18 the distance of peak SNP
between the eQTL and pQTL ranged from 2.6 kb to 1.6 Mb. For
local eQTLs, we found approximately twice as many local eQTLs
as local pQTLs for the 396 genes (79 vs 46). To examine the extent
of overlap between local QTLs, we considered a pQTL and an
eQTL shared if they mapped within 2 Mb of each other. Using
this definition, there were 26 local QTLs shared between the
protein and transcript products of the gene. From these common
QTLs, 8 mapped to the same peak SNP in the genome-wide
association and 18 others mapped in various proximities of each
other ranging from 23 bp to 1.8 Mb. The number of shared local
QTLs suggests that majority of local pQTLs (26/46=56%) are
likely to be conserved at the transcript level, and only 1/3 (26/
79=32%) of eQTLs are conserved at the protein level.
Since local eQTLs are less likely to contain false positives [33],
we utilized them to assess if our definition of significance based on
FDR had any effect of the results of the comparative analysis we
described above. For this, since the transcript local eQTL counts
outnumbered the peptide counts, we set a fixed threshold for
significance in the transcript dataset (5% FDR, p-value,1.69e-05),
counted the number of pQTL overlaps with the significant eQTLs
at varying statistical cutoffs, and asked if the increase in the overlap
was more than what would be expected by chance. For this we
examined results at 5% FDR cutoff, 10% FDR cutoff, and 25%
FDR cutoff. At the 5%FDR (p-value,9.58e-06) there were 46
local pQTLs from which 26 overlapped with the 79 eQTLs.
Decreasing the p-value stringency to detect association in the
protein data, however, did not significantly increase the overlap
between eQTL and pQTL. At the 10% FDR (p-value,2.95e-05)
we detected 56 pQTL from which 28 overlapped with eQTLs (2
more than 5%FDR), and at the 25% FDR (p-value,0.0002) we
detected 68 pQTLs for which the overlap with eQTL was only 29,
one more than 10% FDR cutoff and 3 more than the 5%FDR
cutoff. These non-significant changes in overlap between eQTL
and pQTL suggest that the lack of overlap between eQTL and
pQTL as presented earlier was not due to the genomewide
significance thresholds set for each dataset.
We should emphasize that one limitation of our study originated
from our study design where we utilized different number of mice
per strain to estimate the transcript and the peptide levels. For
transcript levels we profiled the RNA from 3 mice per strain and
estimated transcript levels for genes by averaging over the data
obtained for three mice, but for the LC-MS data we only sampled
one mouse per strain. This design, by its nature, results in a higher
power to detect genome-wide associations and significant
correlations with clinical traits for transcript data in comparison
to the peptide data. In fact, mapping transcript levels by taking
Global Mouse mRNA and Protein Levels Comparison
PLoS Genetics | www.plosgenetics.org 11 June 2011 | Volume 7 | Issue 6 | e1001393only the data from one of the three microarray data for each strain
gave us on average 36% fewer local eQTLs in comparison to what
we had obtained by averaging the expression phenotypes over the
three microarrays (Text S1 and Table S6). This difference would
not change the overall conclusions regarding the commonality and
the differences observed between the peptide and transcript
genome-wide mapping results.
Discussion
We report a comparative analysis of the genetic regulation of the
transcriptome and proteome ina mammaliansystem. By examining
the effects of thousands of genetic perturbations simultaneously on
transcript and protein levels in the HMDP, we were able to
investigate the global nature of relationships between the two. Since
the HMDP was typed for numerous clinical/physiologic traits, we
were also able to study the relationships of these to transcript levels
as compared to protein levels. Finally, we examined the
commonality of genetic drivers affecting transcript and protein
levels. We discuss these points in turn below.
We performed the comparison of protein and transcript levels
using two separate approaches. In one approach we comprehen-
sively compared the LC-MS peptide measurements to the
microarray expression estimates. In the second approach we
examined the relationship between the expression of exons
representing the peptides identified by the LC-MS to the
expression of exons counted in the next generation sequence
data. In addition, to address sources of technical and biologic
variation in our measurements, we filtered peptides with
significant nongenetic variation. In all these analyses we found
that the relationship between the protein expression and transcript
expression was modest at best and in only 50% of the cases did this
relationship reach nominal statistical significance. We also found
that the amount of genetic variation is a predictor of concordance
between peptides and transcripts.
Our data complements the data previously published for yeast
and plant indicating similar modest protein-transcript relationship.
As compared to yeast, we found a slightly higher estimate of
protein-transcript concordance (0.27 vs 0.18 correlation) when
considering all the peptide measurements and significantly higher
estimates (0.42 vs 0.18 correlation) when considering peptides with
large genetic variability. The higher estimates reported here are
likely to be more reflective of the true relationship between protein
and transcript levels as compared to the previous reports mainly
due to the choice of technology used to measure protein levels in
our study. We utilized the differential labeling technique as put
forth by Qian and colleagues where the label free samples are
combined with an internal control labeled with heavy isotope [15].
This mixture is then quantified and the results are reported as the
ratio of sample to the pool for each identified peptide during mass
spectrometry. This strategy, which offers the advantage of
overcoming peptide level variation due to platform robustness,
has been shown to more precisely quantify peptides as compared
to label free methods [15]. This was evident in our study as well
where we showed that in general the variance in technical
replicates was low, with an overall narrow distribution across the
peptides quantified.
Biologically, the modest relationship between the proteins and
transcripts is likely to be explained in part by molecular events
such as translational efficiency, alternative splicing, folding,
assembly into complexes, transport and localization, covalent
modification, secretion, and degradation, all of which affect
protein levels independently of transcripts. The importance of
these post-transcriptional processes is highlighted by a recent
report showing that the presence of genetic variation in some of
these post-transcriptional processes is associated with certain
human diseases [34]. We acknowledge that the design of our
study and our most comprehensive dataset, which was generated
by Affymetric microarrays capturing the 39 end of transcripts,
prevented us from comprehensively addressing the issue of
differential splicing. However, using two complementary ap-
proaches, NGS and concordance level of peptides, we examined
the possibility of differentially regulated isoforms as a predictor for
the lack of concordance between microarray data and LC-MS
data. In neither case did differential splicing appear to contribute
importantly to the lack of transcript-protein correlation.
An unexpected finding was the stronger association of transcript
levels with clinical traits as compared to protein levels with clinical
traits. This is likely due in part to the greater technical difficulties for
the quantification of proteins as compared to transcripts, but the
differences were quite striking and there may be additional
explanations. One possible explanation is that the molecular
phenotypes are reactive to the clinical phenotypes (rather than being
causal)and that thereisincreased buffering at the protein level.Apart
from the strength of the trait associations, the protein and transcript
associations in many cases did not overlap. For example, less than
15% of clinical trait-transcript correlations were replicated when
traits were correlated with the corresponding proteins.
At the genetic level we also found marked differences in the
number and locations of loci controlling protein and transcript
levels. When we directly examined protein-transcript pairs
corresponding to the same gene, we found that the transcript
data had twice as many associations as the protein data. One
plausible explanation for the existence of the differential genetic
regulation between proteins and transcripts is that of ‘‘phenotypic
buffering’’ as put forth previously [11]. An alternative explanation,
however, would be that in general the more removed a phenotype
is from the DNA variation, the more complex the phenotype
becomes. Thus, protein levels would be affected by all the factors
influencing transcript levels as well as numerous additional factors.
The consequence of increasing complexity in the phenotype is that
less of the variation in phenotype would become linked to a single
DNA variation.
In summary, we highlighted the similarities and differences in
genetic regulation of protein and transcript levels. Although a
component of the observed differences in regulation is likely to be
technical, particularly with respect to the protein levels, it is clear
that the proteomics and transcriptomics provide nonoverlapping
information. Thus, these data have important implications for
systems biology approaches that utilize such high throughput data.
They also raise fundamental questions about the complexity of the
relationships between various biological scales involved in complex
genetic traits.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
appropriate committee. All experiments in this paper were carried
out with UCLA IACUC approval.
Animals and clinical phenotype collection
Male mice from the HMDP panel, approximately 6–10 weeks
of age, were purchased from Jackson Labs and were fed Purina
Chow (Ralston-Purina Co., St. Louise, MO) at 16 weeks of age.
All mice were maintained on a 12 h light/dark cycle. At 16 weeks
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determined using a Bruker Optics Minispec nuclear magnetic
resonance (NMR) analyzer (The Woodlands, TX, USA) according
to the manufacturer’s recommendations. We also calculated the
total mass of the mice, sum of lean mass, free fluid, and fat mass,
and body fat percentage, fat mass/total mass. Following a 16-hour
fast, mice were weighed and then bled retro-orbitally under
isoflurane anaesthesia. Complete blood counts were performed
using a Heska CBC-Diff analyzer (Heska Corp, Loveland, CO,
USA). An external control sample with known analyte concentra-
tion was run in each plate to ensure accuracy. Glucose levels were
determined using commercially available kits from Sigma (St
Louis, MO, USA). Insulin levels were measured using commercial
ELISA kits (ALPCO Diagnostics). All measurements were
performed in triplicate according to the manufacturer’s instruc-
tions. Plasma lipids were determined as previously described [35].
Mice were euthanized by cervical dislocation and the mass of
individual tissues and fat depots (heart, kidney, retroperitoneal fat
pad, epididymal fat pad, subcutaneous fat pad, and omental fat
pad) were determined by dissecting and weighing each tissue/pad
separately after the mice were euthanized. Following this, liver
tissues were dissected out, flash frozen in liquid nitrogen, and kept
at 270 degrees until further processing.
RNA isolation, expression profiling, and RNA-Seq
experiment
At 16 weeks of age, the liver tissues of the mice were dissected
out, flash frozen in liquid nitrogen, and kept at 270 degrees until
further processing. For RNA profiling the RNA from 3 mice per
strain were hybridized to Affymetrix Mouse Genome HT_MG-
430A arrays. Frozen liver samples were weighed and homogenized
in Qiazol according to the manufacturer’s protocol. Following
homogenization, RNA extraction was performed using Qiagen’s
RNeasy kit (cat# 74104). Ninety two strains of mice had three
biological replicates, five strains had two biological replicates and
two strains had one biological replicate each. All RNA samples
were cleaned using a Biosprint96 (Qiagen, Valencia, CA) with
RNA cleanup beads (Agencourt Bioscience, Beverly, MA)
following manufacturer’s protocol with adaptations for use with
the Biosprint. The quality of the total RNA from the samples was
monitored by the Agilent 2100 Bioanalyzer (Agilent Technologies,
Palo Alto, CA) and RNA quantity was measured with a
NanoDrop (NanoDrop Technologies, Inc. Wilmington, DE)
following the manufacturer’s instructions. All samples were
arrayed into three 96 well microtiter plates following a randomized
design format that places samples from the same strain on different
plates to better estimate variance across testing strains. All target
labeling reagents were purchased from Affymetrix (Santa Clara,
CA). Double-stranded cDNAs were synthesized from 1 ug total
RNA through reverse transcription with an oligo-dT primer
containing the T7 RNA polymerase promoter and double strand
conversion using the cDNA Synthesis System. Biotin-labeled
cRNA was generated from the cDNA and used to probe
Affymetrix Mouse Genome HT_MG-430A arrays. The
HT_MG-430A Array plate consists of 96 single MG-430A arrays
arranged into standard SBS 96 well plate format. All cDNA and
cRNA target preparation steps were processed on a Caliper
GeneChip Array Station from Affymetrix. Array hybridization,
washing and scanning were performed according to the manu-
facturer’s recommendations. Scanned images were subjected to
visual inspection and a chip quality report was generated by the
Affymetrix’s GeneChipOperating System (GCOS) and Expression
console Affymetrix). Two of 288 chips were excluded due to low
QC scores. The image data was processed using the Affymetrix
GCOS algorithm utilizing quantile normalization or the Robust
Multiarray method (RMA) to determine the specific hybridizing
signal for each gene. Expression data can be obtained from Geo
database (GSE16780). To avoid the effect of SNP on hybridiza-
tion, we matched the location of ,14 million SNPs from dbSNP
database (NCBI) to the location of the individual probes on the
genome. If the location of the probe had a matching SNP within it
we flagged the probe and exclude it from the cdf file prior to RMA
normalization. If a probeset contained SNP in 8 or more 25-mer
probes, we excluded the probeset from the analysis. The cleaned
datasets were then background corrected and normalized using
the affy package (from bioconductor) using rma, pmonly, and
median-polish normalization methods.
RNA isolation for Next Generation Sequencing followed the
same protocol as the one described above for the microarray data.
For the RNA-Seq experiment, two inbred mice (C57BL/6J and
DBA/2J) were chosen. Library preparation was carried using
illumina’s mRNA-Seq 8-Sample Prep Kit protocol (Illumina, cat#
RS-100-0801). In brief, 1 to 10 ug of RNA was used for library
construction. In the first step the poly-A containing mRNA
molecules were purified using poly-T oligo-attached magnetic
beads. Next, the purified mRNA was fragmented into small pieces
using divalent cations, followed by double stranded cDNA
synthesis using random primers, adenylated at the 39 end and
ligated to the sequencing adapters. The ligated products were then
separated on 2% agarose gel, 200 bp fragments were selected and
PCR amplified using PE 1.0 and PE 2.0, and purified using
QIAquick PCR Purification Kit (QIAGEN, part # 28104). The
final library concentration was verified by Bioanalyzer. Sequenc-
ing reaction was performed by Illumina Genome Analyzer 2.0 at
UCLA Human Genetics microarray core. Raw sequences were
uploaded onto Galaxy website (at http://main.g2.bx.psu.edu/)
and using the Tophat software [22] was aligned against the
reference genome (M. musculus, mm9) downloaded from UCSC.
Alignment was performed by setting the parameter for misalign-
ment to one. Relative abundance of transcripts (in Fragments Per
Kilobase of Exon per Million read sequence units) was estimated
using the Cufflink software [23] and the Ensembl’s Mus_musculus
NCBIM37 as the reference annotation file.
Protein isolation and sample preparation
Male mice were euthanized using isoflurane followed by cervical
dislocation at 6–10 weeks of age. The liver tissue was immediately
frozen in dry ice until further processing. The 97 samples
corresponding to different mouse strains plus some extra samples
from C57BL/6J mouse were randomized into 10 batches of 10
samples. Each batch was processed separately prior to quantitative
LC-MS analysis. Before the LC-MS analysis the batches were put
together and the sample list was randomized one more time. The
extraction and digestion of the proteins was performed using a
commonly used protocol based on denaturation of protein in 8 M
urea followed by digestion with trypsin. Briefly, approximately
5 mg of liver tissue was resuspended in 100 ul denaturing solution
(8 M urea, 50 mM Tris-HCl pH 8.0 and 1 mM EDTA) and
homogenized with a motorized pestle. Upon homogenization, the
total protein content was measured by Bicinchoninic Protein Assay
(BCA, Pierce, Rockford, IL) and the 500 ug aliquots were taken
from each sample for further processing. DTT was added to a
concentration of 10 mM in sample, then to solubilize and unfold
the proteins the samples were incubated for 30 min at 37oC with
shaking. Cysteine residues were alkylated by adding iodoaceta-
mide up to 40 mM concentration and incubating for 1 hour at
37oC, with shaking, in the dark. For protein digestion the samples
were diluted 10-fold with 50 mM ammonium bicarbonate
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incubated for 3 hours at 37oC with shaking. The sample digests
were purified with solid phase extraction using C18 columns
(Discovery DSC-18, SUPELCO, 52601-U), lyophilized and
resuspended in 25 mM ammonium bicarbonate pH 7.8. The
peptide amounts were estimated with BCA assay. On the average
the amount of purified tryptic peptides was 200 ug. To generate
the 18O reference sample, 20 ug of each sample was pooled, then
boiled 10 minutes, followed by immediate cooling for 10 minutes.
The boiling/cooling steps were performed to inactivate trypsin
(this step helps to avoid back-exchange of 18O-labeled peptides).
The pooled reference was then subjected to solution-phase tryptic
18O exchange, followed by quenching of tryptic activity with
formic acid. The pooled sample was then added in equal amounts
with each individual sample for quantitation purposes.
Characterization of the mouse liver proteome
Construction of a library of proteins and tryptic peptides present
in the liver is an important step for follow-up quantitation. 10 ug
aliquots from all 97 strains were pooled together and subjected to
LC fractionation by strong cation exchange (SCX) chromatogra-
phy on a 200 mm62.1 mm Polysulfoethyl A column (PolyLC,
Columbia, MD) preceded by a 10 mm62.1 mm guard column,
using a flow rate of 0.2 mL/min. LC separations were performed
using an Agilent 1100 series HPLC system (Agilent, Palo Alto,
CA). Mobile phase solvents consisted of (A) 10 mM ammonium
formate, 25% acetonitrile, pH 3.0 and (B) 500 mM ammonium
formate, 25% acetonitrile, pH 6.8. Once loaded, isocratic
conditions at 100% A were maintained for 10 min. Peptides were
separated by using a gradient from 0–50% B over 40 min,
followed by a gradient of 50–100% B over 10 min. The gradient
was then held at 100% solvent B for another 10 min. Following
lyophilization, all thirty fractions collected during this gradient
were dissolved in 25 mM ammonium bicarbonate and stored at
280OC.
Each SCX fraction was analyzed with an automated custom-
built capillary HPLC system coupled online to an LTQ ion trap
mass spectrometer (Thermo Fisher, San Jose, CA) by using an
electrospray ionization interface. The reversed phase capillary
column was prepared by slurry packing 3-mm Jupiter C18 particles
(Phenomenex, Torrance, CA) into a 75 mm i.d.665 cm fused silica
capillary (Polymicro Technologies, Phoenix, AZ). The mobile
phase solvents consisted of (A) 0.2% acetic acid and 0.05% TFA in
water and (B) 0.1% TFA in 90% acetonitrile. An exponential
gradient was used for the separation, which started with 100% A,
and gradually increased to 60% B over 100 min. The instrument
was operated in a data-dependent mode with an m/z range of
400–2000. Ten most abundant ions from each MS scan were
selected for further MS/MS analysis by using a normalized
collision energy setting of 35%. Dynamic exclusion was applied to
avoid repeat analyses of the same abundant precursor ion.
The SEQUEST software (Thermo Fisher) was used to search
the MS/MS data against the mouse International Protein Index
(IPI) database (version 3.52 http://www.ebi.ac.uk/IPI). Human
keratins and porcine trypsin were added into the database as
expected contaminants. Trypsin cleavage specificity was required
for all of the considered peptides. The following criteria were used
to filter raw SEQUEST results: 1) Xcorr$1.9 and Del-
taCn2$0.21 for charge state +1; 2) Xcorr$2.5 and Del-
taCn2$0.26 for charge state +2; 3) Xcorr$2.8 and Del-
taCn2$0.32 for charge state +3. These criteria provide the
maximum number of peptide identifications not exceeding 1%
false discovery rate (FDR). To estimate the FDR of peptide
identifications we searched against a reversed database as
previously described [36].
Relative protein abundance quantitation
Relative peptide and protein quantitation was based on ratios
between intensities of natural
16O isotope containing peptides and
reference peptides labeled with stable
18O isotope at the carbonyl
group at the C-terminus of the peptide. To create a reference
sample we pooled together 20 ug aliquots from all strains and
labeled the C-termini with
18O isotopes using trypsin catalyzed
exchange in the presence of heavy H2
18O water as described
above and elsewhere [37]. Prior to the LC-MS analysis 3.75 ug
aliquots from each individual sample were mixed with the same
amount of 18O-labeled reference sample.
The 7 ug aliquots were analyzed on a LTQ-Orbitrap mass
spectrometer that was interfaced with a 75 um i.d.665 cm long
LC column packed with 3 um Jupiter C18 particles (Phenom-
enex). The mobile phase solvents consisted of (A) 0.2% acetic acid
and 0.05% TFA in water and (B) 0.1% TFA in 90% acetonitrile.
An exponential gradient was used for the separation, which started
with 100% A and gradually increased to 60% B over 100 min.
LC-MS datasets were analyzed by in-house software VIPER [38]
that detected features in mass – elution time space and assigned
them to peptides in AMT tag database as described elsewhere
[39,40]. Typically an LC-MS run identifies ,3,500 16O/18O
peptide pairs that co-elute with a 4.0085 Da mass difference.
As we mentioned before, the relative abundances of tryptic
peptides were calculated as the ratio between light and heavy
isotopes. The relative abundances then were normalized with
EigenMS procedure [41] to correct systematic biases that may
arise for example from unequal sample loading, batch-to-batch
differences in sample processing and LC column variability.
Briefly, the EigenMS procedure discovers the systematic trends
(so-called eigenpeptides) in the data using singular value
decomposition and then removes contributions of those eigenpe-
pides from each peptide. For all data analysis purposes the peptide
and protein intensities were log2 transformed and zero-centered
by subtracting the peptide or protein specific means taken across
all the samples.
Immunobloting experiments
To determine the protein levels by immunobloting, liver
samples were homogenized in RIPA including phosphatase and
protease inhibitors (Santa Cruz Biotech sc-24948), and protein
determination were done using the Biorad Dc Assay. Protein
samples were boiled following addition of Laemmli loading dye,
separated on Invitrogen precast gels, and transferred to PVDF
membranes. Membranes were rinsed in 16TBST (Cell signaling
#9997) blocked in 5% skim milk-TBST, rinsed in TBST, and
incubated with primary antibodies diluted in 3% BSA-TBST for
1 hr at 23degC or overnight at 4degC. Membranes were washed
in TBST and incubated with an HRP-conjugated anti rabbit IgG
KPL (#474-1516) 1/5000 in 5% skim milk-TBST. Membranes
were washed again, incubated in ECL-plus, and signal detected
using a Biorad Chemidoc or film. Densitometry was done using
the Biorad Quantity One software. The following list of antibodies
and working dilutions were used for each protein: Fasn (Cell
Signaling cat #3180, 1/2000), Acyl (Cell Signaling cat #4332, 1/
2000), Ywhae (Cell Signaling cat #9635, 1/2000), Vim (Cell
Signaling cat#3932, 1/1000), Rkip (Cell Signaling cat#5291, 1/
2000), Gapdh (Cell Signaling cat#3683, 1/5,000), Glo1 (Sigma
Chemical SAB1100242, 1/20,000), GstA4 (Sigma Chemical
SAB1100244, 1/20,000), AnxA5 (Sigma Chemical AV36687, 1/
2000), Hao1 (Sigma Chemical AV42480, 1/2000), Aldh3A2
Global Mouse mRNA and Protein Levels Comparison
PLoS Genetics | www.plosgenetics.org 14 June 2011 | Volume 7 | Issue 6 | e1001393(Sigma Chemical HPA014769, 1/20,000), Actin (Sigma Chemical
A2066, 1/5,000), Acox1 (Abnova PAB4367, 1/2000).
Data filtering
For transcript data we applied three filtering steps based on 1)
genetic heritability, 2) probeset annotation. We have profiled 3
mice per strain which allowed us to estimate the broad sense
heritability for each transcript. Broad sense heritability for each
transcript was measured using ANOVA where strain information
was used as a grouping factor. The broad sense heritability which
is defined as the ratio of genetic variance over total variance for
the phenotype was estimated by dividing the sum of squares of
the strain information factor over total sum of squares in the
ANOVA. The significance of heritability was established if the p-
value for the strain information term in ANOVA was below the
nominal 0.05 threshold. The selection cutoff for including gene in
the analysis based on heritability was set to heritability p-value of
0.05. From the 22700 probesets 10186 probesets did not meet
this cutoff. For annotation filtering, we acquired the Ensembl
Gene ID for each Affymetrix probeset and selected those
probesets that were only annotated to only one Ensembl gene.
From the initial 22700 probesets, 4401 probesets had ambiguous
annotation (either did not map to a gene or mapped to more than
2 Ensembl genes). Overall, 9896 probesets met both filtering
criteria (significant heritability and unique Ensembl annotation).
For the protein data, the initial filtering steps were based on 1)
eliminating peptides with excessive missing values which would
otherwise have unreliable mapping information, 2) eliminating
peptides with missed internal cleavage sites which cause
unreliable measurement. To annotate peptides we utilized the
SpliceCenter web-based tool [42] to obtain the location of the
exon each peptide represents. Peptides which mapped to multiple
exons of more than one gene (as determined by SpliceCenter)
were excluded from the analysis because of ambiguous annota-
tion. The genomic exon coordinates for each peptide was then
used to query the Ensembl database to acquire the Ensembl Gene
IDs. In the second step of filtering peptides that had more than
the value of 2 for the ratio of total variance over technical
variance were chosen. Overall, 1543 peptides met the two-stage
filtering described above.
Genotyping and genome-wide association mapping
Inbred strains were previously genotyped by the Broad Institute
(http://www.broadinstitute.org/mouse/hapmap ), and they were
combined with the genotypes from Wellcome Trust Center for
Human Genetics (WTCHG). Genotypes of RI strains at the Broad
SNPs were inferred from WTCHG genotypes by interpolating
alleles at polymorphic SNPs among parental strains, calling
ambiguous genotypes missing. Of the 140,000 SNPs available,
95,854 were informative with an allele frequency greater than
10% and missing values in less than 10% of the strains. These
SNPs were used for both protein and transcript genome-wide
association analysis.
We applied the following linear mixed model to account for the
population structure and genetic relatedness among strains in the
genome-wide association mapping [27]: y=m+xb+u+e.
In the formula, m represents mean, x represents SNP effect, u
represents random effects due to genetic relatedness with
Var(u)=sg
2K and Var(e)=se
2, where K represents IBS (identi-
ty-by-state) matrix across all genotypes in the HMDP panel. A
restricted maximum likelihood (REML) estimate of sg
2 and se
2
are computed using EMMA, and the association mapping is
performed based on the estimated variance component with a
standard F-test to test b?0. We applied EMMA (Efficient Mixed
ModelAssociation) asan R implementation of a linear mixed model.
The percent of variance explained for each molecular phenotype
was calculated using the SNP effect calculated from EMMA by
defining it as 1-(variance of residuals/variance of original pheno-
types). It should be noted that since EMMA is orders of magnitude
faster than other implementations commonly used, we were able to
perform statistical analyses for all pairs of transcripts and genome
wide markers in a few hours using a cluster of 50 processors. Both
pQTL and eQTL were defined as ‘‘local’’ if the peak association
SNP position was within a 4 Mb interval, flanking 2 Mb on either
side of the transcription start and end of the gene under regulation.
Genome-wide cutoff: Genome-wide cutoffs were calculated as the false
discovery rates using the ‘‘qvalue’’ package for FDR calculation in
the R statistical software [43]. Due to the computational complexity
associated with evaluating q-values for over 400 million p-values, we
computed the FDRs by taking the average FDR for 100 samples
each containing 5 million randomly selected p-values from the
original calculated p-values. FDR calculation was carried out
separately for the protein and transcript dataset.
GO analysis and other statistical methods/software
All statistical analyses and data visualizations were carried out
using the R statistical software (available at http://cran.r-project.
org/). Classification of proteins and transcripts to various GO
categories was accomplished using Mouse Genome Informatics
website at Jackson Laboratories and the GO ontology tool at
Princeton. For each probe and each peptide, we first obtained the
MGI IDs using the MGI batch query tool at http://www.
informatics.jax.org/ [44]. Using MGI IDs we utilized the GO
Term Mapper at http://go.princeton.edu, which is based on
map2slim algorithm [45] to obtain the GO annotations and
summary statistics. The background geneset used in this analysis
wasthe list ofallgenesannotatedbyMGI.To assessthe significance
of the correlation coefficients observed in the PT-pair GO analysis,
for each GO category we created 100,000 bootstrap datasets each
equal in size to the number of genes assigned to the GO term.
Bootstrapping was carried out randomly and without replacement
from the pool of 584 original correlation p-values among the PT-
pairs. The significance of the observed average p-values for each
GO term is reported as the two-tailed test against the empirical
distribution created by the corresponding 100,000 permutation set.
All the correlation coefficients and corresponding p-values reported
in the paper are calculated using the bicor function in the WGCNA
R package [46]. The main advantage of using bicor, which
performs biweight midcorrelation calculation, over Pearson’s
correlation is based the robustness of the correlation coefficient
measurement to the presence of outliers in the data.
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